Author:
Ondrusova M.,Ondrus D.,Miskovska V.,Kajo K.,Szoldova K.,Usakova V.,Stastna V.
Funder
Slovak Research and Development Agency
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11 [Internet]. IARC, Lyon. http://globocan.iarc.fr
2. Oldenburg J, Fossa SD, Nuver J, Heidenreich A, Schmoll HJ et al (2013) Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):25–32
3. De Wit R, Fizazi K (2006) Controversies in the management of clinical stage I testis cancer. J Clin Oncol 24:5482–5492
4. Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M et al (2015) Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 26:833–838
5. Nichols CR, Roth B, Albers P, Einhorn LH, Foster R et al (2013) Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 31:3490–3493